Jet Lag
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:24
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Jet Lag Formulated for symptoms associated with travel such as fatigue, insomnia, headaches and digestive discomfort.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.
OTC - ACTIVE INGREDIENT SECTION
Alumina 15x, Aralia quinquefolia 15x, Arg. nit. 15x, Arnica 15x, Arsenicum alb. 15x, Baptisia 15x, Bryonia 15x, Cantharis 15x, Chelidonium majus 15x, Conium 15x, Gelsemium 15x, Iodium 15x, Kali carb. 15x, Kali iod. 15x, Lycopodium 15x, Lycopus virginicus 15x, Nat. mur. 15x, Nux vom. 15x, Phosphorus 15x, Phytolacca 15x, Pulsatilla 15x, Rhus toxicodendron 15x, Sabal 15x, Thyroidinum 15x, Echinacea 3x.
OTC - PURPOSE SECTION
Formulated for symptoms associated with travel such as fatigue, insomnia, headaches and digestive discomfort.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-1118-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f1a0-f424-e053-dadaa90a57ce | Jet Lag |
| 55714-1118-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f1a0-f424-e053-dadaa90a57ce | Jet Lag |
| 55714-1118-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f1a0-f424-e053-dadaa90a57ce | Jet Lag |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-1118-0 | Jet Lag | 7.08 g in 1 BOTTLE, GLASS | PELLET | 7.08 | 1 | |
| 55714-1118-1 | Jet Lag | 28.35 g in 1 BOTTLE, GLASS | PELLET | 28.35 | 1 | |
| 55714-1118-2 | Jet Lag | 56.7 g in 1 BOTTLE, GLASS | PELLET | 56.7 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-1118 | JET LAG (ALUMINA, ARALIA QUINQUEFOLIA, ARG. NIT., ARNICA, ARSENICUM ALB., BAPTISIA, BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CONIUM, GELSEMIUM, IODIUM, KALI CARB., KALI IOD., LYCOPODIUM, LYCOPUS VIRGINICUS, NAT. MUR., NUX VOM., PHOSPHORUS, PHYTOLACCA, PULSATILLA, RHUS TOXICODENDRON, SABAL, THYROIDINUM, ECHINACEA) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC, 3 package rows | 20140128_113401d2-2169-eb86-ee67-6bea8efed9fc.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aluminum Oxide | ACTIVE INGREDIENT | LMI26O6933 | 1 | |
| American Ginseng | ACTIVE INGREDIENT | 8W75VCV53Q | 1 | |
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Baptisia Tinctoria | ACTIVE INGREDIENT | 5K1UO2888Y | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| Conium Maculatum Flowering Top | ACTIVE INGREDIENT | Q28R5GF371 | 1 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| Iodine | ACTIVE INGREDIENT | 9679TC07X4 | 1 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| Lycopus Virginicus | ACTIVE INGREDIENT | TWH5125Q6F | 1 | |
| Lytta Vesicatoria | ACTIVE INGREDIENT | 3Q034RO3BT | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Phytolacca Americana Root | ACTIVE INGREDIENT | 11E6VI8VEG | 1 | |
| Potassium Carbonate | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| Potassium Iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| Saw Palmetto | ACTIVE INGREDIENT | J7WWH9M8QS | 1 | |
| Silver Nitrate | ACTIVE INGREDIENT | 95IT3W8JZE | 1 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Thyroid, Unspecified | ACTIVE INGREDIENT | 0B4FDL9I6P | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| Aluminum Oxide | ACTIVE MOIETY | LMI26O6933 | 1 | |
| American Ginseng | ACTIVE MOIETY | 8W75VCV53Q | 1 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Baptisia Tinctoria | ACTIVE MOIETY | 5K1UO2888Y | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Carbonate Ion | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| Chloride Ion | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| Conium Maculatum Flowering Top | ACTIVE MOIETY | Q28R5GF371 | 1 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| Iodide Ion | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| Iodine | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 1 | |
| Lycopus Virginicus | ACTIVE MOIETY | TWH5125Q6F | 1 | |
| Lytta Vesicatoria | ACTIVE MOIETY | 3Q034RO3BT | 1 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| Phytolacca Americana Root | ACTIVE MOIETY | 11E6VI8VEG | 1 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 1 | |
| Saw Palmetto | ACTIVE MOIETY | J7WWH9M8QS | 1 | |
| Silver Cation | ACTIVE MOIETY | 57N7B0K90A | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Thyroid, Unspecified | ACTIVE MOIETY | 0B4FDL9I6P | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Jet Lag
- Alumina, Aralia quinquefolia, Arg. nit., Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Conium, Gelsemium, Iodium, Kali carb., Kali iod., Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Phytolacca, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea
- Aluminum Oxide
- American Ginseng
- Silver Nitrate
- Silver Cation
- Arnica Montana
- Arsenic Trioxide
- Arsenic Cation (3+)
- Baptisia Tinctoria
- Bryonia Alba Root
- Lytta Vesicatoria
- Chelidonium Majus
- Conium Maculatum Flowering Top
- Gelsemium Sempervirens Root
- Iodine
- Potassium Carbonate
- Carbonate Ion
- Potassium Iodide
- Iodide Ion
- Lycopodium Clavatum Spore
- Lycopus Virginicus
- Sodium Chloride
- Chloride Ion
- Strychnos Nux-vomica Seed
- Phosphorus
- Phytolacca Americana Root
- Pulsatilla Vulgaris
- Toxicodendron Pubescens Leaf
- Saw Palmetto
- Thyroid, Unspecified
- Echinacea, Unspecified
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-1118 | 55714-1118-1, 55714-1118-2, 55714-1118-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b8a8592d-20d3-a64d-5ffb-b37e9d175059 | 113401d2-2169-eb86-ee67-6bea8efed9fc | 2011-03-01 | Warnings | b8a8592d-20d3-a64d-5ffb-b37e9d175059 113401d2-2169-eb86-ee67-6bea8efed9fc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
